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Background
Systemic sclerosis (SSc) is a chronic disease characterised
by systemic inflammation, vasculopathy and fibrosis.
Primary myocardial disease occurs in both limited (lcSSc)
and diffuse (dcSSc) cutaneous subtypes, and carries a
poor prognosis. The natural history is poorly understood,
with no clear approach to identifying the ‘at-risk’ patient.
CMR studies in SSc have rarely correlated with disease
phenotype. Our objective is to determine cardiovascular
manifestations of SSc using multi-component CMR.
Methods
Eleven patients fulfilling SSc ACR/Le-Roy criteria, with-
out known CV disease or diabetes, underwent CMR at
3.0T (Philips Achieva TX). Data from 10 healthy sub-
jects served as a control group. Standard bSSFP cine
images were acquired and LV dimensions calculated.
First-pass perfusion imaging in three short-axis LV slices
was performed during administration of 0.1 mmol/kg of
gadobutrol at 3 minutes of 140 mcg/kg/min adenosine
for stress and repeated 15 minutes later at rest. Myocar-
dial perfusion reserve (MPR) was calculated using Fermi
deconvolution (PMI v.0.4, [Sourbron, 2009] with basal
blood pool providing the arterial input. Native and
15 minute post final contrast T1 maps were generated
from mid-LV short axis using a modified 3,3,5 Look-
Locker inversion sequence to calculate extra-cellular
volume (ECV) fraction.
Results
Patient characteristics were as follows: Mean age 54 ±
16, disease duration 9.6 ± 7.3 years, 7 female, 7 lcSSc
subtype, 4 dcSSc subtype, 5 interstitial lung disease.
Smoking status: 1 current, 8 ex-smoker, 2 never. 3 have
known hypertension. CMR measurements are presented
in Table 1. One patient with lsSSc subtype showed lat-
eral mid-ventricular wall enhancement on LGE. ECV
increased and MPR decreased with age (r = 0.657, p =
0.039; rho= -0.75, p = 0.02 respectively). A non-signifi-
cant trend for a higher ECV was noted in lcSSc subtype
(mean ECV 33% vs. 28% dcSSc subtype, p = 0.14). ECV
was similar for disease duration (mean ECV 33% > 10
years vs. 30% < 10 years, p = 0.2). MPR was non-signifi-
cantly lower in lcSSc subtype (mean 1.83 vs. 2.13 in
dcSSc subtype, p = 0.3) and there was no strong associa-
tion with disease duration. MPR in SSc was lower than
in healthy controls (n = 9) (1.9 versus 2.8, p = 0.03).
Conclusions
CMR demonstrates lower MPR in patients with SSc
than in controls. Our preliminary data suggest that
quantitative CMR may also be able to detect differences
in myocardial involvement in subtypes of the disease,
justifying future larger studies.
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Table 1 CMR measurements in eleven patients with
systemic sclerosis
Variable Mean (SD)
End-diastolic volume index (ml/m2) 85 (19)
End-systolic volume index (ml/m2) 32 (10)
Stroke volume index (ml/m2) 53 (11)
LV ejection fraction index (%/m2) 38 (6)
LV mass index (g/m2) 46 (9)
Extra-cellular volume fraction (%) 32 (5)
Myocardial perfusion reserve 1.9 (0.4)
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